Yesterday, we had an intelligent, helpful meeting with an intelligent, helpful oncologist. (Credit where it’s due.)
The gist of what we learned was this:
The original herceptin trial had 3 arms: no herceptin, a year of herceptin, and 2 years of herceptin. The survival rates from the 1-year arm of the trial were so dramatic compared to [...]
Subscribe

